Price Crosses Moving Average
|Bid||0.00 x 900|
|Ask||0.00 x 1200|
|Day's Range||60.74 - 64.32|
|52 Week Range||20.63 - 82.00|
|Beta (5Y Monthly)||1.95|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 01, 2023 - May 05, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||107.00|
Subscribe to Yahoo Finance Plus to view Fair Value for AXSM
Three Fool.com contributors have ideas on up-and-coming growth stocks to buy right now. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Sarepta Therapeutics (NASDAQ: SRPT), and Travere Therapeutics (NASDAQ: TVTX). Keith Speights (Axsome Therapeutics): Some small drugmakers have all of their eggs in one basket with only one pipeline candidate.
One is a well-established, large-cap drugmaker, while the other is still making a name for itself in the industry.
There are no guarantees that any stock will generate huge returns. But the odds look pretty good for these three growth stocks.